Jean Adams v. Novo Nordisk A/S

Good Law
United States Court of Appeals for the Ninth CircuitMarch 28, 202221-55342California872 words

Opinion

Opinion

FILED

NOT FOR PUBLICATION

MAR 28 2022

UNITED STATES COURT OF APPEALS MOLLY C. DWYER, CLERK

U.S. COURT OF APPEALS

FOR THE NINTH CIRCUIT

In re: INCRETIN-BASED THERAPIES No. 21-55342

PRODUCTS LIABILITY LITIGATION,

______________________________ D.C. No. 3:13-md-02452-AJB-MDD JEAN ADAMS, On Behalf of Herself and All Other Similarly Situated Plaintiffs,

MEMORANDUM*

Plaintiff-Appellant,

v.

NOVO NORDISK A/S,

Defendant-Appellee.

Appeal from the United States District Court for the Southern District of California Anthony J. Battaglia, District Judge, Presiding

Argued and Submitted March 7, 2022 San Francisco, California

Before: S.R. THOMAS and McKEOWN, Circuit Judges, and ORRICK,** District Judge.

* This disposition is not appropriate for publication and is not precedent except as provided by Ninth Circuit Rule 36-3. ** The Honorable William Horsley Orrick, United States District Judge for the Northern District of California, sitting by designation. Jean Adams, on behalf of herself and similarly situated plaintiffs, appeals the

summary judgment granted by the district court in favor of Novo Nordisk A/S

(“Novo”)…

Sign in to read the full opinion

Create a free account to read the complete opinion text, citation history, and good-law status for this case.